Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

Recruiting now

Conditions studied: Mild Autonomous Cortisol Secretion (MACS)

In brief

The aim of the proposed study is to estimate the incidence of Mild Autonomous Cortisol Secretion (MACS) in patients with Adrenal Incidentaloma (AI) and evaluate the available diagnostic tests to determine the most sensitive and specific combination of tests for assessing MACS from adrenal adenoma for prediction of the phenotype associated with cortisol excess. As well as following the patients for 4 years and see if anything changes.

Key facts

Study ID
NCT06344143
Run by
The Cleveland Clinic
People needed
20
Starts
2024-11-20
Expected to finish
2030-12-31
Last updated by the study team
2026-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.